The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours

被引:55
作者
Ferreira, E. [1 ]
Bertagnolli, A. C. [1 ]
Cavalcanti, M. F. [1 ]
Schmitt, F. C. [2 ]
Cassali, G. D. [1 ]
机构
[1] Univ Fed Minas Gerais, Lab Comparat Pathol, Dept Gen Pathol, Inst Biol Sci, BR-48631270 Belo Horizonte, MG, Brazil
[2] Univ Porto, Inst Mol Pathol & Immunol, Oporto, Portugal
关键词
dog; immunohistochemical; mammary tumour; survival time; tumour size; BREAST-CANCER; MIXED TUMORS; RECEPTORS; ESTROGEN; P53; C-ERBB-2; SALIVARY; GLANDS;
D O I
10.1111/j.1476-5829.2009.00193.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Tumour size is considered one of the most important determinants of clinical staging in cancer patients. The aim of this study was to assess the value of tumour size as an indicator of the differentiation of mammary neoplasias in female dogs. The tumour, nodes metastates (TNM) system, based on primary lesion size, the extent of its dissemination to regional lymph nodes and the presence or absence of distant metastases, was applied to 120 female dogs diagnosed with mammary neoplasias. Paraffin blocks from 38 cases were selected and studied by immunohistochemical staining for prognostic and predictive markers of breast cancer. The Kaplan-Meier survival curve was estimated for 110 female dogs. Larger tumours (T3) were mostly malignant and showed lower expression of progesterone receptor and higher expression of cellular proliferation markers. Global survival time was shorter in female dogs with large tumour masses. This study highlights the importance of tumour size as a prognostic indicator of mammary neoplasias in female dogs.
引用
收藏
页码:230 / 235
页数:6
相关论文
共 29 条
[1]  
Auclair PL, 1996, MODERN PATHOL, V9, P652
[2]   Immunohistochemical Expression of p63 and ΔNp63 in Mixed Tumors of Canine Mammary Glands and Its Relation with p53 Expression [J].
Bertagnolli, A. C. ;
Cassali, G. D. ;
Genelhu, M. C. L. S. ;
Costa, F. A. ;
Oliveira, J. F. C. ;
Goncalves, P. B. D. .
VETERINARY PATHOLOGY, 2009, 46 (03) :407-415
[3]   PROGNOSIS FOLLOWING SURGICAL EXCISION OF CANINE MAMMARY NEOPLASMS [J].
BOSTOCK, DE .
EUROPEAN JOURNAL OF CANCER, 1975, 11 (06) :389-&
[4]  
CASTIGLIONI T, 1995, MEDICINA-BUENOS AIRE, V55, P415
[5]   DEMONSTRATION OF ESTROGEN, ANDROGEN AND PROGESTAGEN RECEPTORS IN THE CYTOSOL FRACTION OF CANINE MAMMARY-TUMORS [J].
DARVILLE, CN ;
PIERREPOINT, CG .
EUROPEAN JOURNAL OF CANCER, 1979, 15 (06) :875-883
[6]  
de las Mulas JM, 2003, BREAST CANCER RES TR, V80, P363, DOI 10.1023/A:1024929730165
[7]  
DENARDI AB, 2005, VET COMP ONCOL, V3, P56
[8]   c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors [J].
Dutra, AP ;
Granja, NVM ;
Schmitt, FC ;
Cassali, GD .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2004, 37 (11) :1673-1681
[9]  
Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966
[10]   A comparative study between mixed-type tumours from human salivary and canine mammary glands [J].
Genelhu, Marisa C. L. S. ;
Cardoso, Sergio V. ;
Gobbi, Helenice ;
Cassali, Geovanni D. .
BMC CANCER, 2007, 7 (1)